Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Development Phase Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global EClinical Solutions Market, By Product
7.1. EClinical Solutions Market, by Product, 2021-2030
7.1.1. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Clinical Trial Management Systems (CTMS)
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Clinical Analytics PlatDelivery Modes
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Randomization and Trial Supply Management (RTSM)
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Clinical Data Integration PlatDelivery Modes
7.1.5.1. Market Revenue and Forecast (2019-2030)
7.1.6. Electronic Clinical Outcome Assessment (eCOA)
7.1.6.1. Market Revenue and Forecast (2019-2030)
7.1.7. Safety Solutions
7.1.7.1. Market Revenue and Forecast (2019-2030)
7.1.8. Electronic Trial Master File (eTMF)
7.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global EClinical Solutions Market, By Delivery Mode
8.1. EClinical Solutions Market, by Delivery Mode, 2021-2030
8.1.1. Web-hosted (On demand)
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Licensed Enterprise (On premise)
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Cloud-based
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global EClinical Solutions Market, By Development Phase
9.1. EClinical Solutions Market, by Development Phase, 2021-2030
9.1.1. Phase I
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Phase II
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Phase III
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Phase IV
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global EClinical Solutions Market, By Application
10.1. EClinical Solutions Market, by Application, 2021-2030
10.1.1. Hospitals/Healthcare providers
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. CROs
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pharma & Biotech Organizations
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Medical Device Manufacturers
10.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global EClinical Solutions Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.1.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.1.4. Market Revenue and Forecast, by Application (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.1.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.1.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.1.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.8.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.8.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.8.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.5.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.5.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.5.6.4. Market Revenue and Forecast, by Application (2019-2030)
Chapter 12. Company Profiles
12.1. Datatrak International, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Parexel International Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Dassault Systemes
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bioclinica
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CRF Health
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ERT Clinical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. IBM Watson Health
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Anju Life Sciences Software
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms